[ad_1] The FDA has granted lorlatinib (Lorbrena) an accelerated approval for the treatment of patients with ALK-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on 1 or more ALK tyrosine …
Read More »Sanofi: FDA Approves Asthma Indication for Dupixent® (Dupilumab)
[ad_1] FDA Approves Asthma Indication For Dupixent® (Dupilumab) Only approved biologics for moderate and severe asthmatic patients with eosinophilic phenotype Only biological product approved for oral asthma dependent on corticosteroids, no matter …
Read More »Magnetic system approved by the FDA to guide lymphatic biopsies
[ad_1] THURSDAY, July 26, 2018 – A magnetic system to guide lymph node biopsies in some people with breast cancer has been approved by the US Food and Drug Administration The Sentimag …
Read More »FDA Commissioner says kratom is not worth the risk of Salmonella
[ad_1] Publisher's rating: Blissful Remedies is the latest brand of kratom products recalled Users of kratom supplements may be at risk for Salmonella infections from of a product that has no nutritional …
Read More »US FDA statement on the permanent risk of salmonella in kratom products | North America
[ad_1] As of February this year, many products containing kratom have been associated with a major outbreak of salmonellosis. The FDA has now completed its investigation for several months after identifying extremely …
Read More »FDA Completes Probe in Kratom Salmonella Link – Pain News Network
[ad_1] "This means that users of these products have essentially one in two chance of being exposed to this pathogen," said Gottlieb and Ostroff. "The contamination rate of more than 50 percent …
Read More »